News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
622,577 Results
Type
Article (47856)
Company Profile (220)
Press Release (574501)
Section
Business (177415)
Career Advice (2593)
Deals (32661)
Drug Delivery (122)
Drug Development (79090)
Employer Resources (161)
FDA (16316)
Job Trends (13650)
News (314148)
Policy (32502)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (3)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2418)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (74)
Alliances (44895)
ALS (80)
Alzheimer's disease (1404)
Antibody-drug conjugate (ADC) (122)
Approvals (16268)
Artificial intelligence (230)
Autoimmune disease (13)
Automation (10)
Bankruptcy (324)
Best Places to Work (10206)
BIOSECURE Act (21)
Biosimilars (103)
Biotechnology (115)
Bladder cancer (55)
Brain cancer (26)
Breast cancer (232)
Cancer (1804)
Cardiovascular disease (144)
Career advice (2157)
Career pathing (32)
CAR-T (133)
Cell therapy (389)
Cervical cancer (14)
Clinical research (63915)
Collaboration (680)
Compensation (408)
Complete response letters (28)
COVID-19 (2653)
CRISPR (36)
C-suite (183)
Cystic fibrosis (94)
Data (1675)
Decentralized trials (2)
Denatured (26)
Depression (46)
Diabetes (234)
Diagnostics (5607)
Digital health (16)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (106)
Drug pricing (119)
Drug shortages (32)
Duchenne muscular dystrophy (68)
Earnings (69744)
Editorial (36)
Employer branding (20)
Employer resources (145)
Events (94252)
Executive appointments (581)
FDA (17311)
Featured Employer (45)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (577)
Gene editing (89)
Generative AI (23)
Gene therapy (278)
GLP-1 (764)
Government (4013)
Grass and pollen (4)
Guidances (43)
Healthcare (16034)
Huntington's disease (24)
IgA nephropathy (23)
Immunology and inflammation (104)
Indications (23)
Infectious disease (2779)
Inflammatory bowel disease (132)
Inflation Reduction Act (9)
Influenza (43)
Intellectual property (71)
Interviews (474)
IPO (15346)
IRA (49)
Job creations (3863)
Job search strategy (1815)
Kidney cancer (10)
Labor market (24)
Layoffs (497)
Leadership (19)
Legal (7870)
Liver cancer (72)
Lung cancer (264)
Lymphoma (125)
Machine learning (2)
Management (57)
Manufacturing (263)
MASH (61)
Medical device (11551)
Medtech (11555)
Mergers & acquisitions (17727)
Metabolic disorders (653)
Multiple sclerosis (65)
NASH (23)
Neurodegenerative disease (81)
Neuropsychiatric disorders (30)
Neuroscience (1871)
NextGen: Class of 2025 (5533)
Non-profit (3438)
Northern California (2143)
Now hiring (26)
Obesity (367)
Opinion (249)
Ovarian cancer (56)
Pain (76)
Pancreatic cancer (67)
Parkinson's disease (125)
Partnered (14)
Patents (185)
Patient recruitment (80)
Peanut (45)
People (52186)
Pharmaceutical (90)
Pharmacy benefit managers (21)
Phase I (19691)
Phase II (27775)
Phase III (21630)
Pipeline (833)
Podcasts (98)
Policy (125)
Postmarket research (2611)
Preclinical (7958)
Press Release (50)
Prostate cancer (88)
Psychedelics (37)
Radiopharmaceuticals (239)
Rare diseases (361)
Real estate (5410)
Recruiting (64)
Regulatory (22553)
Reports (32)
Research institute (2227)
Resumes & cover letters (427)
Rett syndrome (3)
RNA editing (1)
RSV (41)
Schizophrenia (71)
Series A (113)
Series B (66)
Service/supplier (13)
Sickle cell disease (53)
Southern California (1811)
Special edition (17)
Sponsored (32)
Startups (3335)
State (2)
Stomach cancer (15)
Supply chain (61)
The Weekly (71)
United States (18581)
Vaccines (713)
Venture capitalists (35)
Webinars (13)
Weight loss (278)
Women's health (32)
Worklife (16)
Date
Last 7 days (665)
Last 30 days (2724)
Last 365 days (32959)
2025 (5916)
2024 (33913)
2023 (37973)
2022 (48622)
2021 (52398)
2020 (49774)
2019 (40611)
2018 (31005)
2017 (31309)
2016 (30111)
2015 (33776)
2014 (27447)
2013 (23079)
2012 (24736)
2011 (25346)
2010 (23294)
Location
Africa (788)
Alabama (40)
Alaska (7)
Arizona (174)
Arkansas (11)
Asia (38851)
Australia (6443)
California (4824)
Canada (1555)
China (403)
Colorado (225)
Connecticut (250)
Delaware (117)
Europe (87563)
Florida (727)
Georgia (154)
Hawaii (1)
Idaho (44)
Illinois (424)
India (21)
Indiana (237)
Iowa (7)
Japan (128)
Kansas (85)
Kentucky (21)
Louisiana (7)
Maine (62)
Maryland (773)
Massachusetts (3759)
Michigan (171)
Minnesota (310)
Mississippi (1)
Missouri (61)
Montana (18)
Nebraska (22)
Nevada (50)
New Hampshire (52)
New Jersey (1407)
New Mexico (25)
New York (1361)
North Carolina (869)
North Dakota (6)
Northern California (2143)
Ohio (153)
Oklahoma (9)
Oregon (31)
Pennsylvania (1064)
Puerto Rico (7)
Rhode Island (19)
South America (1163)
South Carolina (13)
South Dakota (1)
Southern California (1811)
Tennessee (77)
Texas (696)
Utah (134)
Virginia (116)
Washington D.C. (58)
Washington State (466)
West Virginia (3)
Wisconsin (45)
622,577 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zealand Pharma convenes its Annual General Meeting 2025
February 20, 2025
·
1 min read
Press Releases
Zealand Pharma Announces Financial Results for the Full Year 2024
February 20, 2025
·
11 min read
Press Releases
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
February 20, 2025
·
11 min read
Complete response letters
Zealand Hit With CRL for Ultrarare Genetic Disease Treatment
The rejection is related to the timing of the FDA’s reinspection of Zealand’s third-party manufacturer, which previously had deficiencies.
October 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
February 14, 2025
·
1 min read
Press Releases
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
January 8, 2025
·
2 min read
Business
Zealand Pharma Announces Financial Results for the First Quarter of 2024
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the interim report for the three months ended March 31, 2024, and provided a corporate update.
May 16, 2024
·
10 min read
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that Adam Steensberg, President and CEO, will participate in fireside chats at the following healthcare investor conferences in June.
May 29, 2024
·
1 min read
Drug Development
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
June 7, 2024
·
7 min read
Press Releases
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
January 7, 2025
·
1 min read
1 of 62,258
Next
